Literature DB >> 4706908

Metoclopramide in gastrooesophageal reflux.

C Stanciu, J R Bennett.   

Abstract

In 30 patients with gastrooesophageal reflux, intravenous metoclopramide (Maxolon) has been shown to increase the gastrooesophageal sphincter pressure. The rise is dose-related until a maximum pressure, proportional to the resting sphincter tone, is reached. The effect is reversed by atropine. Peristaltic waves are increased in pressure by metoclopramide.In 18 patients with gastrooesophageal reflux intravenous metoclopramide diminished the frequency of reflux episodes and increased the rate at which the oesophagus emptied itself of an acid load.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4706908      PMCID: PMC1412597          DOI: 10.1136/gut.14.4.275

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  A MULTIPHASE ESOPHAGEAL PH TEST FOR GASTROESOPHAGEAL REFLUX.

Authors:  V A PICCONE; J R GUTELIUS; J R MCCORRISTON
Journal:  Surgery       Date:  1965-05       Impact factor: 3.982

2.  Acid clearing from the distal esophagus.

Authors:  D J Booth; W T Kemmerer; D B Skinner
Journal:  Arch Surg       Date:  1968-05

3.  Assessment of distal esophageal function in patients with hiatal hernia and-or gastroesophageal reflux.

Authors:  D B Skinner; D J Booth
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

4.  [Action of methoclopramide on different portions of isolated rabbit intestine and on the "in situ" intestine].

Authors:  D Coullaud; J Lévêque
Journal:  Pathol Biol       Date:  1966-10

5.  The effect of metoclopramide on the gastroesophageal junctional zone and the distal esophagus in man.

Authors:  P Heitmann; N Möller
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

6.  Gastrointestinal effects of metoclopramide in man. In vitro experiments with human smooth muscle preparations.

Authors:  M Eisner
Journal:  Br Med J       Date:  1968-12-14

7.  Effect of intravenous metoclopramide on gastrooesophageal reflux.

Authors:  J N Glanville; W D Walls
Journal:  Gut       Date:  1972-01       Impact factor: 23.059

  7 in total
  17 in total

1.  Reflux esophagitis.

Authors:  W J Dodds; W J Hogan; W N Miller
Journal:  Am J Dig Dis       Date:  1976-01

Review 2.  Some aspects of medical management of gastrointestinal disease. I.

Authors:  B W Badley
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

3.  Diagnosing hiatus hernia.

Authors:  G E Sinclair
Journal:  Can Fam Physician       Date:  1978-10       Impact factor: 3.275

4.  A double-blind dose ranging study of BRL 24924 and metoclopramide on lower oesophageal sphincter pressure in healthy volunteers.

Authors:  C S Robertson; S J Ledingham; S M Cooper; D F Evans
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

5.  [Applications of endoscopy, manometry, and conservative therapy (author's transl)].

Authors:  M Wienbeck
Journal:  Langenbecks Arch Chir       Date:  1974

6.  Amyloidosis mimics achalasia's effect on lower esophageal sphincter.

Authors:  J R Lefkowitz; D L Brand; M D Schuffler; W R Brugge
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

7.  Oesophageal acid clearing: one factor in the production of reflux oesophagitis.

Authors:  C Stanciu; J R Bennett
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

8.  L-Dopa inhibits metoclopramide stimulation of the lower esophageal sphincter in man.

Authors:  H W Baumann; A L Sturdevant; R W McCallum
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

Review 9.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Metoclopramide inhibits development of esophageal varices in rat model.

Authors:  M Ohta; M Hashizume; K Tanoue; K Ueno; K Komori; T Ishii; S Kitano; K Sugimachi
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.